Addus HomeCare Earnings Call Highlights Growth And Scale

Addus HomeCare Corporation ((ADUS)) has held its Q4 earnings call. Read on for the main highlights of the call.

Addus HomeCare’s latest earnings call struck an upbeat tone, with management emphasizing robust revenue growth, expanding profitability and a strengthened balance sheet. While they acknowledged pockets of pressure in margins, home health and working capital, the overall message was that strategic acquisitions, rate increases and operational investments are driving sustainable momentum.

Robust Revenue Growth Across Quarter and Full Year

Addus reported Q4 2025 revenue of $373.1 million, up 25.6% year over year, capping a strong year of expansion. Full‑year 2025 revenue reached roughly $1.4 billion, an impressive 23.2% increase that reflects both solid organic trends and contributions from recent acquisitions.

Profitability Strength and Margin Expansion

Adjusted EBITDA in Q4 climbed 33.3% to $50.3 million, lifting the EBITDA margin to 13.6% from 12.9% a year earlier. For 2025, adjusted EBITDA rose 28.3% to $180 million, with adjusted EPS advancing 28.3% in Q4 to $1.77 and 18.4% for the year to $6.23.

Personal Care Growth Outpaces Expectations

The core Personal Care segment delivered same‑store revenue growth of 6.3% in Q4, beating the company’s 3%–5% target range and supported by a 2.4% increase in same‑store hours. Personal Care generated $284.1 million of revenue in the quarter, representing 76.5% of total sales and underscoring its role as Addus’s growth engine.

Hospice Segment Delivers Double‑Digit Growth

Hospice operations maintained strong momentum, with same‑store revenue up 16% year over year in Q4 and average daily census rising 11.9% to 3,885. The segment represented 18.9% of quarterly revenue and benefited from a roughly 3.1% Medicare reimbursement increase effective October 1, 2025.

Acquisitions Extend Scale and Market Coverage

The Gentiva personal care acquisition, completed in December 2024, added roughly $280 million in annualized revenue and expanded Addus’s footprint. Additional 2025 deals, including Great Lakes, Helping Hands and Del Cielo, built density in key markets and bolstered personal care scale, feeding into the company’s strong top‑line performance.

Balance Sheet Strength and Deleveraging Progress

Addus exited 2025 with $81.6 million of cash and total bank debt of $124.3 million, leaving net leverage under 1x adjusted EBITDA. The company generated $111.5 million in operating cash flow for the year, reduced its revolver balance by $98.7 million and retained $517.7 million of revolver availability to support future deals.

State Rate Increases Provide Tailwinds

Favorable Medicaid rate actions are adding fuel to growth, including a roughly 9.9% Texas personal care hike that took effect September 1, 2025. Illinois implemented a 3.9% personal care rate increase on January 1, 2026, expected to contribute around $17.5 million in annualized revenue with margins in the low‑20% range, while New Mexico may see a further 4%–5% boost.

Hiring Momentum and Technology Upgrades

Operationally, Addus is ramping capacity, averaging 101 hires per business day in Q4 and roughly 107 early in January before winter storms temporarily slowed activity. The company is rolling out a caregiver app, already widely adopted in Illinois and expanding into New Mexico and Texas, alongside deployment of Homecare Homebase to improve scheduling, documentation and efficiency.

Home Health Segment Remains Under Pressure

Home Health same‑store revenue fell 7.4% in Q4 and remained the smallest business at just 4.6% of total revenue, or $17.1 million. Management is investing in new leadership and sales resources, but cautioned that a return to growth is more likely in the second half of 2026 given reimbursement and demand headwinds.

Slight Softness in Same‑Store Census

Same‑store billable census declined 1.1% year over year in the quarter and edged down sequentially, as normal seasonality and localized issues weighed on volumes. Even so, management noted that most major states saw census growth, suggesting the softness is manageable rather than structural.

Gross Margin Compression and Near‑Term Cost Headwinds

Q4 gross margin slipped to 32.8% from 33.4% a year earlier, largely due to a higher mix of lower‑margin personal care from recent acquisitions. The company also flagged near‑term pressure, with expectations for about 120 basis points of sequential gross margin decline in Q1 2026 from annual merit raises and payroll tax resets.

DSO Volatility and Receivables Timing Issues

Days sales outstanding increased to 38.2 days in Q4 from 35 days in the prior quarter, temporarily weighing on cash flow. Illinois was the main swing factor, with DSO spiking to 54.7 days from 32.5 days on timing differences that have already begun normalizing in early 2026.

Weather‑Related Operational Disruptions

Severe winter storms in late January contributed to short‑term hiring slowdowns and a number of missed or rescheduled personal care visits. Management indicated that staffing metrics and field operations recovered in February, pointing to a transient impact rather than a lasting constraint.

Policy and Reimbursement Risks in the Background

Investors were reminded that policy risk remains, particularly around potential Medicaid changes tied to OB3 and 80‑20 provisions, though management is cautiously optimistic on outcomes. Future home health rate moves and any retrospective payment adjustments also cloud visibility for the clinical services segment.

Wage Pass‑Through Dynamics Could Temper Margins

In markets like New Mexico, rate increases are not governed by strict pass‑through formulas, which gives operators some flexibility but also pressures them to share gains with caregivers. Addus expects to pass along a portion of any legislative hikes, which may limit margin expansion even as revenue benefits.

Guidance and Forward‑Looking Outlook

Looking ahead to Q1 2026, Addus expects a revenue lift from the Illinois rate increase of about $17.5 million annualized, partially offset by two fewer personal care business days and lingering storm effects. Management forecasts a roughly 120‑basis‑point sequential gross margin decline in Q1 and a full‑year tax rate in the mid‑20% range, while maintaining a disciplined capital allocation stance and targeting selective acquisitions alongside further debt reduction.

Addus HomeCare’s call framed a company leveraging acquisitions, state rate wins and operational investments to deliver double‑digit growth and rising earnings, even as it manages manageable headwinds. For investors, the story is one of a solid balance sheet, strong personal care and hospice trends, and clear plans to address weaker home health, suggesting the growth runway remains intact.